Subscribe to RSS
DOI: 10.1055/s-0028-1103272
© Georg Thieme Verlag KG Stuttgart · New York
ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
Publication History
received 23.01.2008
revised 24.06.2008
accepted 21.10.2008
Publication Date:
22 January 2009 (online)

Abstract
P-glycoprotein (P-gp/ABCB1), multidrug resistance associated protein 1 (MRP1/ABCC1), and breast cancer resistance protein (BCRP/ABCG2) are plasma membrane efflux pumps that limit the intracellular uptake and retention of numerous lipophilic, amphipathic xeno- and endobiotics. Little is known about the neonatal and developmental expression of P-gp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 in the human central nervous system (CNS), therefore post-mortem CNS tissue from infants born at 220/7–420/7 weeks of gestation and adults was immunostained to determine their ontogeny and cellular localization. P-gp/ABCB1 immunostaining was observed in microvessel endothelial cells as early as 220/7 weeks, increasing in prevalence and intensity with maturation, and later in gestation in large pyramidal neurons. MRP1/ABCC1 immunostaining was prominent early in the choroid plexus and ventricular ependyma, and noted later in large pyramidal neurons. BCRP/ABCG2 expression was limited to microvessel endothelial cells. P-gp/ABCB1, MRP1/ABCC1 and BCRP/ABCG2 in adult brain matched term newborn CNS but with more intense immunostaining. We conclude that P-gp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 are expressed in a developmental, cell specific, fashion in the human CNS. The complementary pattern of P-gp/ABCB1 and BCRP/ABCG2 at the blood-brain with MRP1/ABCC1 at the blood-CSF barriers may limit CNS uptake and retention of drugs and toxins in neonates.
Key words
BCRP - P-glycoprotein - MRP1 - blood-brain barrier - human neonates
References
- 1 Ahdab-Barmada M, Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropathol Exp Neurol. 1984; 43 45-56
- 2 Ak H, Ay B, Tanriverdi T. et al . Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia. Seizure. 2007; 16 493-503
- 3 Aronica E, Gorter JA, Jansen GH. et al . Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience. 2003; 118 417-429
- 4 Aronica E, Gorter JA, Redeker S. et al . Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia. 2005; 46 849-857
- 5 Beaulieu E, Demeule M, Ghitescu L. et al . P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J. 1997; 326 539-544
- 6 Bendayan R, Ronaldson PT, Gingras D. et al . In situ localization of P-gycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem. 2006; 54 1159-1167
- 7 Conlee JW, Shapiro SM. Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis. Acta Neuropathol. 1997; 93 450-460
- 8 Cooray HC, Blackmore CG, Maskell L. et al . Localization of breast cancer resistance protein in microvessel endothelium of human brain. Neuro Report. 2002; 13 2059-2063
- 9 Cordon-Cardo C, O’Brien JP, Casals D. et al . Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 1989; 86 695-698
- 10 Debus E, Weber K, Osborn M. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation. 1983; 25 193-203
- 11 Decleves X, Regina A, Laplanche JL. et al . Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J Neurosci Res. 2000; 60 594-601
- 12 Diestra JE, Scheffer GL, Catala I. et al . Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol. 2002; 198 213-219
- 13 Engidawork E, Roberts JC, Hardmeier R. et al . Expression of the multidrug resistance associated protein (MRP1) in Down syndrome brains. J Neurol Transm Suppl. 2001; 61 35-45
- 14 Fernetti C, Pascolo L, Podda E. et al . Preparation of an antibody recognizing both human and rodent MRP1. Biochem Biophys Res Comm. 2001; 288 1064-1068
- 15 Flens MJ, Zaman GJ, Valk P van der. et al . Tissue distribution of the multidrug resistance protein. Am J Pathol. 1996; 148 1237-1247
- 16 Georges E, Bradley G, Gariepy J. et al . Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci USA. 1990; 87 152-156
- 17 Ginn PE. Immunohistochemical detection of P-glycoprotein in formalin-fixed paraffin-embedded normal and neoplastic canine tissues. Vet Pathol. 1996; 33 533-541
- 18 Golden PL, Partridge WM. P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res. 1999; 819 143-146
- 19 Goralski KB, Acott PD, Frasere AD. et al . Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression. Drug Metab Dispos. 2006; 34 288-295
- 20 Hockberger PE, Yousif L, Nam SC. Identification of acutely isolated cells from developing rat cerebellum. Neuroimage. 1994; 1 276-287
- 21 Jette L, Tetu B, Beliveau R. High levels of P-glycoprotein detected in isolated brain capillaries. Biochim Biophys Acta. 1993; 1150 147-154
- 22 Johnson DR, Finch RA, Lin ZP. et al . The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Res. 2001; 61 1469-1476
- 23 Lazarowski A, Lubieniecki F, Camarero HT. et al . Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol. 2004; 30 102-106
- 24 Lazarowski A, Caltana L, Merelli A. et al . Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection. J Neurol Sci. 2007; 258 84-92
- 25 Leslie EM, Deeley RG, Cole SPC. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005; 204 216-237
- 26 Matsuoka Y, Okazaki M, Kitamura Y. et al . Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol. 1999; 39 383-392
- 27 Nies AT, Jedlitschky, Konig J. et al . Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience. 2004; 129 349-360
- 28 Ostrow JD, Pascolo L, Brites D. et al . Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med. 2004; 10 65-70
- 29 Pavelic ZP, Sever Z, Fontaine RN. et al . Detection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissues. Sel Cancer Ther. 1989; 7 49-58
- 30 Ramos AJ, Lazarowski A, Villar MJ. et al . Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization. Cell Mol Neurobiol. 2004; 24 101-107
- 31 Rao VV, Dahlheimer JL, Bardgett ME. et al . Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier. Proc Natl Acad Sci USA. 1999; 96 3900-3905
- 32 Regina A, Koman A, Piciotti M. et al . Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem. 1998; 71 705-715
- 33 Rosati A, Maniori S, Decorti G. et al . Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Develop Growth Differ. 2003; 45 377-387
- 34 Sawasaki Y, Yamada N, Nakajima H. Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinemia. J Neurochem. 1976; 27 577-583
- 35 Scheffer GL, Kool M, Heijn M. et al . Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and P-glycoprotein with a panel of monoclonal antibodies. Cancer Res. 2000; 60 5269-5277
- 36 Schumacher U, Mollgard K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol. 1997; 108 179-182
- 37 Seetharaman S, Barrand MA, Maskell L. et al . Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J Neurochem. 1998; 70 1151-1159
- 38 Sisodiya SM, Lin WR, Harding BN. et al . Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain. 2002; 125 22-31
- 39 Sisodiya SM, Martinian L, Scheffer GL. et al . Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies. Neuropathol Appl Neurobiol. 2006; 32 51-63
- 40 Toth K, Vaughn MM, Slocum HK. et al . New immunohistochemical “sandwich” staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am J Pathol. 1994; 144 227-236
- 41 Tsai C, Daood MJ, Lane RH. et al . P-glycoprotein expression in mouse brain increases with maturation. Biol Neonate. 2002; 81 58-64
- 42 Kalken CK van, Giaccone G, Valk P van der. et al . Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol. 1992; 141 1063-1072
- 43 Virgintino D, Robertson D, Errede M. et al . Expression of P-glycoprotein in human cerebral cortex microvessels. J Histochem Cytochem. 2002; 501 1671-1676
- 44 Virgintino D, Errede M, Girolamo F. et al . Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol.. 2008; 67 50-61
- 45 Volk HA, Burkhardt K, Potschka H. et al . Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience. 204; 123 751-759
- 46 Watchko JF, Daood MJ, Hansen TWR. Brain bilirubin content is increased in P-glycoprotein deficient transgenic null mutant mice. Pediatr Res. 1998; 44 763-766
- 47 Watchko JF, Daood MJ, Mahmood B. et al . P-glycoprotein and bilirubin disposition in the neonate. J Perinatol. 2001; 21 S43-S47
- 48 Zhang W, Mojsilovic-Petrovic J, Andrade MF. et al . The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 2003; 17 2085-2087
Correspondence
J. F. WatchkoMD
Division of Newborn Medicine
Department of Pediatrics
Magee-Womens Hospital
300 Halket Street
Pittsburgh
15213 Pennsylvania
USA
Phone: +1/412/641 18 34
Fax: +1/412/641 53 13
Email: jwatchko@mail.magee.edu